Literature DB >> 22461456

Analysis of skeletal dysplasias in the Utah population.

David A Stevenson1, John C Carey, Janice L B Byrne, Sivithee Srisukhumbowornchai, Marcia L Feldkamp.   

Abstract

The Utah Birth Defect Network (UBDN) collects population-based data for Utah on births from all resident women. The prevalence of skeletal dysplasias and epidemiologic characteristics/outcomes were evaluated. Cases categorized as a skeletal dysplasia from all live births, stillbirths, and pregnancy terminations (TAB) between 1999 and 2008 were reviewed by three clinical geneticists. After case review, 153 were included for analysis (88% live births, 3% stillborn, 9% TAB), and categorized by groupings defined by molecular, biochemical, and/or radiographic criteria as outlined in the 2010 Nosology and Classification of Genetic Skeletal Disorders. The overall prevalence for skeletal dysplasias was 3.0 per 10,000 births, and 20.0 per 10,000 stillbirths. The most common diagnostic groups were osteogenesis imperfecta (OI; n = 40; 0.79 per 10,000), thanatophoric dysplasia (n = 22; 0.43 per 10,000), achondroplasia (n = 18; 0.35 per 10,000), and cleidocranial dysplasia (n = 6; 0.12 per 10,000). The most common groups based on the 2010 Nosology and Classification of Genetic Skeletal Disorders were the FGFR3 chondrodysplasia group (n = 41; 0.81 per 10,000), the OI/decreased bone density group (n = 40; 0.79 per 10,000), and the type 2 collagen group (n = 10; 0.2 per 10,000). Median age of postnatal diagnosis was 30 days (range 1-2,162). Of those deceased, 88% were prenatally suspected; of those alive 29% prenatally suspected. Median age of death for live born individuals was 1 day (range 1-1,450 days). Previously reported prevalence rates vary, but our data provide a population-based approach not limited to the perinatal/neonatal period. Understanding the range for survival within each group/diagnosis is beneficial for health care providers when counseling families.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22461456     DOI: 10.1002/ajmg.a.35327

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.

Authors:  He Xu; Sydney A Lenhart; Emily Y Chu; Michael B Chavez; Helen F Wimer; Milena Dimori; Martha J Somerman; Roy Morello; Brian L Foster; Nan E Hatch
Journal:  Dev Dyn       Date:  2020-03-12       Impact factor: 3.780

Review 2.  Advances in the Classification and Treatment of Osteogenesis Imperfecta.

Authors:  Inas H Thomas; Linda A DiMeglio
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 3.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

4.  Identification of a Recognizable Progressive Skeletal Dysplasia Caused by RSPRY1 Mutations.

Authors:  Maha Faden; Fatema AlZahrani; Roberto Mendoza-Londono; Lucie Dupuis; Taila Hartley; Peter Kannu; Julian A Raiman; Andrew Howard; Wen Qin; Martine Tetreault; Joan Qiongchao Xi; Imadeddin Al-Thamer; Richard L Maas; Kym Boycott; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2015-09-10       Impact factor: 11.025

Review 5.  Sulphate in pregnancy.

Authors:  Paul A Dawson; Aoife Elliott; Francis G Bowling
Journal:  Nutrients       Date:  2015-03-04       Impact factor: 5.717

6.  A novel de novo COL1A1 mutation in a Thai boy with osteogenesis imperfecta born to consanguineous parents.

Authors:  Siraprapa Tongkobpetch; Noppachart Limpaphayom; Apiruk Sangsin; Thantrira Porntaveetus; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Genet Mol Biol       Date:  2017-09-21       Impact factor: 1.771

7.  Etiology and clinical presentation of birth defects: population based study.

Authors:  Marcia L Feldkamp; John C Carey; Janice L B Byrne; Sergey Krikov; Lorenzo D Botto
Journal:  BMJ       Date:  2017-05-30

8.  Diagnostic utility of next-generation sequence genetic panel testing in children presenting with a clinically significant fracture history.

Authors:  Jennifer Harrington; Abdulmajeed AlSubaihin; Lucie Dupuis; Peter Kannu; Roberto Mendoza-Londono; Andrew Howard
Journal:  Arch Osteoporos       Date:  2021-06-05       Impact factor: 2.617

9.  Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.

Authors:  Zeng Zhang; Mei Li; Jin-Wei He; Wen-Zhen Fu; Chang-Qing Zhang; Zhen-Lin Zhang
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

Review 10.  Ethical language and decision-making for prenatally diagnosed lethal malformations.

Authors:  Dominic Wilkinson; Lachlan de Crespigny; Vicki Xafis
Journal:  Semin Fetal Neonatal Med       Date:  2014-09-05       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.